Cholecystokinin (CCK) is a classical gastrointestinal hormone produced from the proximal small intestine. It possesses a number of physiologic actions including regulation of pancreatic exocrine secretion, gallbladder contraction, gastric emptying, and perhaps satiety. Regulation of CCK secretion has been studied primarily by examining plasma levels of the hormone in animals and humans or in perfused intestinal segments. Although these methods are critical for understanding the physiology of CCK, they are limited in that they do not permit examination of the mechanisms that regulate CCK at the cellular level. The Principal Investigator has recently developed a method for isolating cells from the proximal small intestine in rats and enriching the CCK cells to 90% purity using a flow cytometer fluorescence-activated cell sorting technique. This method is based on the ability of monitor peptide (a CCK-releasing peptide) to selectively stimulate calcium fluxes in CCK cells and thereby provide a signal for separating CCK cells from a mixed population of intestinal cells loaded with the calcium-sensitive fluorescent dye, Indo-1 AM. These purified CCK cells retain viability and secrete CCK in response to specific secretagogues. The major advantage of this technique is that it provides a means of studying a single population of CCK cells, apart from other possible interfering influences such as neural, hormonal, or paracrine effects. The objectives of the proposed research plan are to use isolated CCK cells to (1) determine the neurotransmitters and hormones that directly regulate CCK secretion, and (2) characterize the second messenger pathways that mediate CCK release. These studies should provide insight into the cellular mechanisms that regulate CCK secretion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK038626-05
Application #
3238043
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1988-07-14
Project End
1995-06-30
Budget Start
1991-07-25
Budget End
1992-06-30
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Bohórquez, Diego V; Liddle, Rodger A (2011) Axon-like basal processes in enteroendocrine cells: characteristics and potential targets. Clin Transl Sci 4:387-91
Chandra, Rashmi; Liddle, Rodger A (2011) Recent advances in pancreatic endocrine and exocrine secretion. Curr Opin Gastroenterol 27:439-43
Bohórquez, Diego V; Chandra, Rashmi; Samsa, Leigh Ann et al. (2011) Characterization of basal pseudopod-like processes in ileal and colonic PYY cells. J Mol Histol 42:3-13
Wang, Yu; Chandra, Rashmi; Samsa, Leigh Ann et al. (2011) Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor. Am J Physiol Gastrointest Liver Physiol 300:G528-37
Nathan, Jaimie D; Romac, Joelle; Peng, Ruth Y et al. (2010) Protection against chronic pancreatitis and pancreatic fibrosis in mice overexpressing pancreatic secretory trypsin inhibitor. Pancreas 39:e24-30
Romac, Joelle M-J; Ohmuraya, Masaki; Bittner, Cathy et al. (2010) Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotype. Am J Physiol Gastrointest Liver Physiol 298:G518-24
Chandra, Rashmi; Liddle, Rodger A (2009) Neural and hormonal regulation of pancreatic secretion. Curr Opin Gastroenterol 25:441-6
Chandra, Rashmi; Liddle, Rodger A (2007) Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14:63-7
Liddle, Rodger A (2006) Pathophysiology of SPINK mutations in pancreatic development and disease. Endocrinol Metab Clin North Am 35:345-56, x
Reeve Jr, Joseph R; Liddle, Rodger A; Shively, John E et al. (2006) Sequence variation outside the ""active"" region of dog and rabbit cholecystokinin-58 results in bioactivity differences. Pancreas 32:306-13

Showing the most recent 10 out of 77 publications